Reduction of inorganic phosphate-induced human smooth muscle cells calcification by inhibition of protein kinase A and p38 mitogen-activated protein kinase

被引:18
|
作者
Kang, Jeong-Hun [1 ]
Toita, Riki [2 ]
Asai, Daisuke [3 ]
Yamaoka, Tetsuji [1 ]
Murata, Masaharu [4 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan
[2] Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, Fukuoka 8128582, Japan
[3] St Marianna Univ, Dept Microbiol, Sch Med, Kawasaki, Kanagawa 2168511, Japan
[4] Kyushu Univ, Dept Adv Med Initiat, Fac Med Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
Smooth muscle cell; Calcification; Protein kinase A; Mitogen-activated protein kinase; Alkaline phosphatase; CHRONIC KIDNEY-DISEASE; VASCULAR CALCIFICATION; OSTEOBLASTIC DIFFERENTIATION; PYROPHOSPHATE; OSTEOPONTIN; PREVENTS;
D O I
10.1007/s00380-013-0427-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High levels of serum phosphate are associated with calcification of human smooth muscle cells (HSMCs). We investigated whether inhibition of protein kinase A (PKA) and mitogen-activated protein kinase (MAPK) signals [p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK)] can reduce inorganic phosphate (Pi)-induced HSMC calcification. Inhibition of PKA or p38 MAPK by inhibitors or small interfering RNAs (siRNAs) reduced Ca levels and alkaline phosphatase activities in HSMCs treated with high Pi, but inhibition of ERK1/2 and JNK showed no significant changes. Moreover, there were no significant changes in cell viability on adding siRNAs and three inhibitors (PKA, p38, and MEK1/2), but JNK inhibitor slightly reduced cell viability. These results show that PKA and p38 MAPK are involved in the Pi-induced calcification of HSMCs, and may be good targets for reducing vascular calcification.
引用
收藏
页码:718 / 722
页数:5
相关论文
共 50 条
  • [21] Ceramide Mediates Ox-LDL-Induced Human Vascular Smooth Muscle Cell Calcification via p38 Mitogen-Activated Protein Kinase Signaling
    Liao, Lizhen
    Zhou, Qin
    Song, Yan
    Wu, Weikang
    Yu, Huimin
    Wang, Sheng
    Chen, Yanling
    Ye, Meihong
    Lu, Lihe
    PLOS ONE, 2013, 8 (12):
  • [22] Angiotensin III induces p38 Mitogen-activated protein kinase leading to proliferation of vascular smooth muscle cells
    Alanazi, Ahmed Z.
    Clark, Michelle A.
    PHARMACOLOGICAL REPORTS, 2020, 72 (01) : 246 - 253
  • [23] p38α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli
    Porras, A
    Zuluaga, S
    Black, E
    Valladares, A
    Alvarez, AM
    Ambrosino, C
    Benito, M
    Nebreda, AR
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (02) : 922 - 933
  • [24] The p38 mitogen-activated protein kinase is involved in stress-induced phospholipase D activation in vascular smooth muscle cells
    Min, DS
    Shin, EY
    Kim, EG
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2002, 34 (01): : 38 - 46
  • [25] The p38 mitogen-activated protein kinase is involved in stress-induced phospholipase D activation in vascular smooth muscle cells
    Do Sik Min
    Eun-Young Shin
    Eung-Gook Kim
    Experimental & Molecular Medicine, 2002, 34 : 38 - 46
  • [26] p38 mitogen-activated protein kinase and alkaline phosphatase in human dental pulp cells
    Wang, Feng-Ming
    Zhou, Xuedong
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2006, 102 (01): : 114 - 118
  • [27] Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons
    Heidenreich, KA
    Kummer, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) : 9891 - 9894
  • [28] Inhibition of p38 mitogen-activated protein kinase (MAPK) leads to hypertrophic cardiomyopathy
    Braz, JC
    Bueno, OF
    Wilkins, BJ
    Braunwart, J
    Molkentin, JD
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (07) : A12 - A12
  • [29] Immunosuppressant rapamycin inhibits protein kinase C α and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis
    Oh, CD
    Kim, SJ
    Ju, JW
    Song, WK
    Kim, JH
    Yoo, YJ
    Chun, JS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 427 (03) : 175 - 185
  • [30] Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction
    Mbalaviele, Gabriel
    Anderson, Gary
    Jones, Amy
    De Ciechi, Pamela
    Settle, Steve
    Mnich, Steve
    Thiede, Mark
    Abu-Amer, Yousef
    Portanova, Joseph
    Monahan, Joseph
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (03): : 1044 - 1053